Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression.

× No keyword cloud information.

31 in total

Review 1. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors: Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal: Inflammopharmacology Date: 2012-01-24 Impact factor: 4.473

2. Anti-inflammatory treatment and risk for depression after first-time stroke in a cohort of 147 487 Danish patients.

Authors: Ida Kim Wium-Andersen; Marie Kim Wium-Andersen; Martin Balslev Jørgensen; Merete Osler
Journal: J Psychiatry Neurosci Date: 2017-09 Impact factor: 6.186

3. The role of inflammatory markers in explaining the association between depression and cardiovascular hospitalisations.

Authors: Sarah A Hiles; Amanda L Baker; Theo de Malmanche; Mark McEvoy; Michael Boyle; John Attia
Journal: J Behav Med Date: 2015-04-03

Review 4. Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.

Authors: Michael Maes; Gabriel Nowak; Javier R Caso; Juan Carlos Leza; Cai Song; Marta Kubera; Hans Klein; Piotr Galecki; Cristiano Noto; Enrico Glaab; Rudi Balling; Michael Berk
Journal: Mol Neurobiol Date: 2015-05-02 Impact factor: 5.590

5. Aspirin adherence, depression and one-year prognosis after acute coronary syndrome.

Authors: Nina Rieckmann; Matthew M Burg; Ian M Kronish; William F Chaplin; Joseph E Schwartz; Karina W Davidson
Journal: Psychother Psychosom Date: 2011-06-30 Impact factor: 17.659

6. Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial.

Authors: Michael Berk; Robyn L Woods; Mark R Nelson; Raj C Shah; Christopher M Reid; Elsdon Storey; Sharyn Fitzgerald; Jessica E Lockery; Rory Wolfe; Mohammadreza Mohebbi; Seetal Dodd; Anne M Murray; Nigel Stocks; Paul B Fitzgerald; Catherine Mazza; Bruno Agustini; John J McNeil
Journal: JAMA Psychiatry Date: 2020-10-01 Impact factor: 21.596

7. Biomarkers and clinical staging in psychiatry.

Authors: Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal: World Psychiatry Date: 2014-10 Impact factor: 49.548

Review 8. Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants.

Authors: Mark J Niciu; Daniel C Mathews; Allison C Nugent; Dawn F Ionescu; Maura L Furey; Erica M Richards; Rodrigo Machado-Vieira; Carlos A Zarate
Journal: Depress Anxiety Date: 2013-12-18 Impact factor: 6.505

Review 9. Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors: Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal: CNS Drugs Date: 2014-03 Impact factor: 5.749

Review 10. Sarcopenia and the Common Mental Disorders: a Potential Regulatory Role of Skeletal Muscle on Brain Function?

Authors: Julie A Pasco; Lana J Williams; Felice N Jacka; Nicole Stupka; Sharon L Brennan-Olsen; Kara L Holloway; Michael Berk
Journal: Curr Osteoporos Rep Date: 2015-10 Impact factor: 5.096